Investment Trusts

Worldwide Healthcare

WWH:LSE

Worldwide Healthcare

  • Price (GBX)327.00
  • Today's Change4.00 / 1.24%
  • Shares traded939.11k
  • 1 Year change10.47%
  • Beta0.3901
Data delayed at least 20 minutes, as of Nov 21 2024 17:05 GMT.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceWorldwide Healthcare (Ordinary Share)+9.26%
NAVWorldwide Healthcare (Ordinary Share)+12.35%
Morningstar's BenchmarkMSCI World Health Care GR--

Key statistics

On Thursday, Worldwide Healthcare (WWH:LSE) closed at 327.00, 11.79% above the 52 week low of 292.50 set on Nov 30, 2023.
52-week range
Today
292.50Nov 30 2023372.50Jul 17 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding512.56m
Market cap1.66bn GBP
Total assets1.96bn GBP
Total expense ratio0.86%
High327.00
Low322.50
Previous close323.00
Average volume1.09m
YTD Change+5.14%
Beta0.3901
Diluted NAV (est)374.39
Diluted NAV (last pub)368.39
Premium/Discount-12.66%
Net Gearing0.00%
Annual div (ADY)2.80 GBX
Annual div yield (ADY)0.87%
Div ex-dateJun 13 2024
Div pay-dateJul 24 2024
Next div ex-dateNov 28 2024
Next div pay-dateJan 09 2025
Data delayed at least 20 minutes, as of Nov 21 2024 17:05 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.